Warrants Finder
Your selection:
65 Results
| JY5S3U | Alnylam Pharmaceuticals Inc./OS/Call [270]/JPMD | - | - | 270.000 | call | Alnylam Pharmaceuticals Inc. | - | 59.923% | 0.605 | -0.093 | 3.676 | 12/18/2026 | 0.100 | JP Morgan | ||
| JE8QTK | Alnylam Pharmaceuticals Inc./OS/Call [280]/JPMD | - | - | 280.000 | call | Alnylam Pharmaceuticals Inc. | - | 59.914% | 0.577 | -0.087 | 3.537 | 01/15/2027 | 0.100 | JP Morgan | ||
| JY1431 | Alnylam Pharmaceuticals Inc./OS/Call [280]/JPMD | - | - | 280.000 | call | Alnylam Pharmaceuticals Inc. | - | 59.481% | 0.567 | -0.094 | 3.838 | 12/18/2026 | 0.100 | JP Morgan | ||
| JY3J4F | Alnylam Pharmaceuticals Inc./OS/Call [280]/JPMD | - | - | 280.000 | call | Alnylam Pharmaceuticals Inc. | - | 59.209% | 0.596 | -0.074 | 3.127 | 03/19/2027 | 0.100 | JP Morgan | ||
| JE8QTR | Alnylam Pharmaceuticals Inc./OS/Call [290]/JPMD | - | - | 290.000 | call | Alnylam Pharmaceuticals Inc. | - | 59.337% | 0.540 | -0.086 | 3.693 | 01/15/2027 | 0.100 | JP Morgan | ||
| JE9CS0 | Alnylam Pharmaceuticals Inc./OS/Call [290]/JPMD | - | - | 290.000 | call | Alnylam Pharmaceuticals Inc. | - | 58.833% | 0.574 | -0.074 | 3.205 | 03/19/2027 | 0.100 | JP Morgan | ||
| JY142Y | Alnylam Pharmaceuticals Inc./OS/Call [290]/JPMD | - | - | 290.000 | call | Alnylam Pharmaceuticals Inc. | - | 59.271% | 0.529 | -0.094 | 3.995 | 12/18/2026 | 0.100 | JP Morgan | ||
| JE6KUS | Alnylam Pharmaceuticals Inc./OS/Call [300]/JPMD | - | - | 300.000 | call | Alnylam Pharmaceuticals Inc. | - | 58.586% | 0.493 | -0.093 | 4.176 | 12/18/2026 | 0.100 | JP Morgan | ||
| JE618K | Alnylam Pharmaceuticals Inc./OS/Call [300]/JPMD | - | - | 300.000 | call | Alnylam Pharmaceuticals Inc. | - | 59.061% | 0.510 | -0.086 | 3.815 | 01/15/2027 | 0.100 | JP Morgan | ||
| JE9CS2 | Alnylam Pharmaceuticals Inc./OS/Call [300]/JPMD | - | - | 300.000 | call | Alnylam Pharmaceuticals Inc. | - | 58.287% | 0.538 | -0.074 | 3.341 | 03/19/2027 | 0.100 | JP Morgan | ||
| JY0QBM | Alnylam Pharmaceuticals Inc./OS/Call [300]/JPMD | - | - | 300.000 | call | Alnylam Pharmaceuticals Inc. | - | 60.252% | 0.403 | -0.144 | 6.595 | 09/18/2026 | 0.100 | JP Morgan | ||
| JE69YL | Alnylam Pharmaceuticals Inc./OS/Call [310]/JPMD | - | - | 310.000 | call | Alnylam Pharmaceuticals Inc. | - | 59.727% | 0.348 | -0.135 | 7.035 | 09/18/2026 | 0.100 | JP Morgan | ||
| JE67DT | Alnylam Pharmaceuticals Inc./OS/Call [310]/JPMD | - | - | 310.000 | call | Alnylam Pharmaceuticals Inc. | - | 58.169% | 0.457 | -0.091 | 4.348 | 12/18/2026 | 0.100 | JP Morgan | ||
| JE599U | Alnylam Pharmaceuticals Inc./OS/Call [310]/JPMD | - | - | 310.000 | call | Alnylam Pharmaceuticals Inc. | - | 58.513% | 0.478 | -0.085 | 3.963 | 01/15/2027 | 0.100 | JP Morgan | ||
| JE9CS3 | Alnylam Pharmaceuticals Inc./OS/Call [310]/JPMD | - | - | 310.000 | call | Alnylam Pharmaceuticals Inc. | - | 57.895% | 0.510 | -0.073 | 3.449 | 03/19/2027 | 0.100 | JP Morgan | ||
| JE08JM | Alnylam Pharmaceuticals Inc./OS/Call [320]/JPMD | - | - | 320.000 | call | Alnylam Pharmaceuticals Inc. | - | 59.846% | 0.296 | -0.125 | 7.420 | 09/18/2026 | 0.100 | JP Morgan | ||
| JE7TCU | Alnylam Pharmaceuticals Inc./OS/Call [320]/JPMD | - | - | 320.000 | call | Alnylam Pharmaceuticals Inc. | - | 57.637% | 0.421 | -0.088 | 4.533 | 12/18/2026 | 0.100 | JP Morgan | ||
| JE83Q3 | Alnylam Pharmaceuticals Inc./OS/Call [320]/JPMD | - | - | 320.000 | call | Alnylam Pharmaceuticals Inc. | - | 59.654% | 0.449 | -0.085 | 4.010 | 01/15/2027 | 0.100 | JP Morgan | ||
| JE9CS5 | Alnylam Pharmaceuticals Inc./OS/Call [320]/JPMD | - | - | 320.000 | call | Alnylam Pharmaceuticals Inc. | - | 57.489% | 0.481 | -0.072 | 3.560 | 03/19/2027 | 0.100 | JP Morgan | ||
| JE0XNC | Alnylam Pharmaceuticals Inc./OS/Call [330]/JPMD | - | - | 330.000 | call | Alnylam Pharmaceuticals Inc. | - | 59.047% | 0.254 | -0.114 | 7.875 | 09/18/2026 | 0.100 | JP Morgan | ||
| JE7TCM | Alnylam Pharmaceuticals Inc./OS/Call [330]/JPMD | - | - | 330.000 | call | Alnylam Pharmaceuticals Inc. | - | 57.521% | 0.388 | -0.086 | 4.687 | 12/18/2026 | 0.100 | JP Morgan | ||
| JE618G | Alnylam Pharmaceuticals Inc./OS/Call [330]/JPMD | - | - | 330.000 | call | Alnylam Pharmaceuticals Inc. | - | 58.116% | 0.416 | -0.082 | 4.225 | 01/15/2027 | 0.100 | JP Morgan | ||
| JE9CS4 | Alnylam Pharmaceuticals Inc./OS/Call [330]/JPMD | - | - | 330.000 | call | Alnylam Pharmaceuticals Inc. | - | 57.081% | 0.454 | -0.071 | 3.673 | 03/19/2027 | 0.100 | JP Morgan | ||
| JE12BF | Alnylam Pharmaceuticals Inc./OS/Call [340]/JPMD | - | - | 340.000 | call | Alnylam Pharmaceuticals Inc. | - | 59.490% | 0.214 | -0.103 | 8.208 | 09/18/2026 | 0.100 | JP Morgan | ||
| JE5016 | Alnylam Pharmaceuticals Inc./OS/Call [340]/JPMD | - | - | 340.000 | call | Alnylam Pharmaceuticals Inc. | - | 57.345% | 0.356 | -0.083 | 4.852 | 12/18/2026 | 0.100 | JP Morgan | ||
| JE618M | Alnylam Pharmaceuticals Inc./OS/Call [340]/JPMD | - | - | 340.000 | call | Alnylam Pharmaceuticals Inc. | - | 57.637% | 0.385 | -0.079 | 4.380 | 01/15/2027 | 0.100 | JP Morgan | ||
| JE9CS6 | Alnylam Pharmaceuticals Inc./OS/Call [340]/JPMD | - | - | 340.000 | call | Alnylam Pharmaceuticals Inc. | - | 56.816% | 0.427 | -0.070 | 3.778 | 03/19/2027 | 0.100 | JP Morgan | ||
| JZ6960 | Alnylam Pharmaceuticals Inc./OS/Call [350]/JPMD | - | - | 350.000 | call | Alnylam Pharmaceuticals Inc. | - | 57.573% | 0.353 | -0.076 | 4.520 | 01/15/2027 | 0.100 | JP Morgan | ||
| JE0028 | Alnylam Pharmaceuticals Inc./OS/Call [350]/JPMD | - | - | 350.000 | call | Alnylam Pharmaceuticals Inc. | - | 62.546% | 0.198 | -0.103 | 8.007 | 09/18/2026 | 0.100 | JP Morgan | ||
| JE7JLV | Alnylam Pharmaceuticals Inc./OS/Call [350]/JPMD | - | - | 350.000 | call | Alnylam Pharmaceuticals Inc. | - | 57.211% | 0.326 | -0.080 | 5.010 | 12/18/2026 | 0.100 | JP Morgan | ||
| JE9CS7 | Alnylam Pharmaceuticals Inc./OS/Call [350]/JPMD | - | - | 350.000 | call | Alnylam Pharmaceuticals Inc. | - | 56.593% | 0.398 | -0.068 | 3.894 | 03/19/2027 | 0.100 | JP Morgan | ||
| JH52VL | Alnylam Pharmaceuticals Inc./OS/Call [360]/JPM | - | - | 360.000 | call | Alnylam Pharmaceuticals Inc. | - | 59.720% | 0.341 | -0.078 | 4.442 | 01/15/2027 | 0.100 | JP Morgan | ||
| JE5011 | Alnylam Pharmaceuticals Inc./OS/Call [360]/JPMD | - | - | 360.000 | call | Alnylam Pharmaceuticals Inc. | - | 56.570% | 0.297 | -0.075 | 5.211 | 12/18/2026 | 0.100 | JP Morgan | ||
| JE9CS8 | Alnylam Pharmaceuticals Inc./OS/Call [360]/JPMD | - | - | 360.000 | call | Alnylam Pharmaceuticals Inc. | - | 58.119% | 0.384 | -0.069 | 3.863 | 03/19/2027 | 0.100 | JP Morgan | ||
| JY0QBN | Alnylam Pharmaceuticals Inc./OS/Call [360]/JPMD | - | - | 360.000 | call | Alnylam Pharmaceuticals Inc. | - | 62.875% | 0.170 | -0.093 | 8.273 | 09/18/2026 | 0.100 | JP Morgan | ||
| JH7RAB | Alnylam Pharmaceuticals Inc./OS/Call [370]/JPM | - | - | 370.000 | call | Alnylam Pharmaceuticals Inc. | - | 57.120% | 0.303 | -0.071 | 4.784 | 01/15/2027 | 0.100 | JP Morgan | ||
| JE67DH | Alnylam Pharmaceuticals Inc./OS/Call [370]/JPMD | - | - | 370.000 | call | Alnylam Pharmaceuticals Inc. | - | 59.380% | 0.285 | -0.077 | 5.067 | 12/18/2026 | 0.100 | JP Morgan | ||
| JE9CS9 | Alnylam Pharmaceuticals Inc./OS/Call [370]/JPMD | - | - | 370.000 | call | Alnylam Pharmaceuticals Inc. | - | 56.182% | 0.350 | -0.064 | 4.098 | 03/19/2027 | 0.100 | JP Morgan | ||
| JE7JLX | Alnylam Pharmaceuticals Inc./OS/Call [380]/JPMD | - | - | 380.000 | call | Alnylam Pharmaceuticals Inc. | - | 56.579% | 0.244 | -0.067 | 5.517 | 12/18/2026 | 0.100 | JP Morgan | ||
| JE9CSA | Alnylam Pharmaceuticals Inc./OS/Call [380]/JPMD | - | - | 380.000 | call | Alnylam Pharmaceuticals Inc. | - | 57.674% | 0.339 | -0.065 | 4.057 | 03/19/2027 | 0.100 | JP Morgan | ||
| JY3VQT | Alnylam Pharmaceuticals Inc./OS/Call [380]/JPMD | - | - | 380.000 | call | Alnylam Pharmaceuticals Inc. | - | 57.222% | 0.282 | -0.068 | 4.882 | 01/15/2027 | 0.100 | JP Morgan | ||
| JE9SME | Alnylam Pharmaceuticals Inc./OS/Call [390]/JPMD | - | - | 390.000 | call | Alnylam Pharmaceuticals Inc. | - | 55.787% | 0.306 | -0.060 | 4.303 | 03/19/2027 | 0.100 | JP Morgan | ||
| JY2P4J | Alnylam Pharmaceuticals Inc./OS/Call [390]/JPMD | - | - | 390.000 | call | Alnylam Pharmaceuticals Inc. | - | 57.135% | 0.260 | -0.065 | 5.004 | 01/15/2027 | 0.100 | JP Morgan | ||
| JY2JGF | Alnylam Pharmaceuticals Inc./OS/Call [400]/JPMD | - | - | 400.000 | call | Alnylam Pharmaceuticals Inc. | - | 57.382% | 0.238 | -0.062 | 5.106 | 01/15/2027 | 0.100 | JP Morgan | ||
| JY3J4G | Alnylam Pharmaceuticals Inc./OS/Put [220]/JPMD | - | - | 220.000 | put | Alnylam Pharmaceuticals Inc. | - | 64.901% | -0.235 | -0.050 | 2.427 | 03/19/2027 | 0.100 | JP Morgan | ||
| JY5QP2 | Alnylam Pharmaceuticals Inc./OS/Put [220]/JPMD | - | - | 220.000 | put | Alnylam Pharmaceuticals Inc. | - | 63.714% | -0.221 | -0.062 | 3.440 | 12/18/2026 | 0.100 | JP Morgan | ||
| JE7TCR | Alnylam Pharmaceuticals Inc./OS/Put [240]/JPMD | - | - | 240.000 | put | Alnylam Pharmaceuticals Inc. | - | 62.665% | -0.286 | -0.069 | 3.181 | 12/18/2026 | 0.100 | JP Morgan | ||
| JE83QE | Alnylam Pharmaceuticals Inc./OS/Put [240]/JPMD | - | - | 240.000 | put | Alnylam Pharmaceuticals Inc. | - | 62.332% | -0.282 | -0.062 | 2.883 | 01/15/2027 | 0.100 | JP Morgan | ||
| JE9CRX | Alnylam Pharmaceuticals Inc./OS/Put [240]/JPMD | - | - | 240.000 | put | Alnylam Pharmaceuticals Inc. | - | 63.756% | -0.289 | -0.053 | 2.285 | 03/19/2027 | 0.100 | JP Morgan | ||
| JE1087 | Alnylam Pharmaceuticals Inc./OS/Put [260]/JPMD | - | - | 260.000 | put | Alnylam Pharmaceuticals Inc. | - | 63.176% | -0.373 | -0.130 | 4.902 | 09/18/2026 | 0.100 | JP Morgan |